Keratoprosthesis (artificial cornea transplant)
seen from United States

seen from France
seen from China

seen from United States

seen from Singapore

seen from United States
seen from United States

seen from United Kingdom

seen from Brunei
seen from United States
seen from T1

seen from United States
seen from China
seen from China
seen from United Kingdom
seen from China
seen from Germany
seen from United States
seen from Türkiye

seen from Malaysia
Keratoprosthesis (artificial cornea transplant)
The Keratoprosthesis is a prosthetic made of transparent material, which is replaced by a surgical intervention, the cornea of a patient. This therapeutic procedure is used to improve the vision of those who need a cornea transplant, but it is not possible to carry out, for any complications or previous attempts failed. The diseases which are most commonly used are the thermal or chemical burns from the eye, Stevens-Johnson syndrome, Sjögren's syndrome. #eye #keratoprosthesis #ophthalmology #pathology #surgery #ophthalmologist #usmle #usmlestep2 #usmlestep1 #doctor #doctordconline #nhs #nurse #nursing #mbbs #md #medstudent #medicine #hospital #patient #amc #plab @doctordconline
Keratoprosthesis Market Estimates Showing Surprising Stability in key Business Segments
Global Keratoprosthesis Market - A Report by Fact.MR
Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global keratoprosthesis market. The keratoprosthesis market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the keratoprosthesis market report elaborates the market behavior of each vendor operating in the keratoprosthesis market.
The keratoprosthesis market report considers the following years to present the overall market growth:
History Year: 2014 - 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year: 2019 – 2029
Key findings of the keratoprosthesis market study:
Regional breakdown of the keratoprosthesis market based on predefined taxonomy.
Innovative manufacturing processes implemented by keratoprosthesis market vendors in detail.
Region-wise and country-wise fragmentation of the keratoprosthesis market to grasp the revenue, and growth outlook in these areas.
Changing preferences among consumers across various regions and countries.
Factors (Positive and Negative) impacting the growth of the global keratoprosthesis market.
Request Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=859
On the basis of disease indication, the keratoprosthesis market study consists of:
Bullous Keratopathy
Keratoconus
Keratitis
Others
On the basis of end user, the keratoprosthesis market study incorporates:
Hospitals
Ambulatory Surgical Centers
Others
On the basis of region, the keratoprosthesis market study contains:
North America (U.S., Canada)
Latin America (Argentina, Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan and China (India, Australia & New Zealand)
China
Japan
Middle East and Africa (GCC, South Africa, Rest Of MEA)
Key players analyzed in the keratoprosthesis market study:
Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
Pfizer, Inc
Bayer AG
Bausch & Lomb Incorporated
Queries addressed in the keratoprosthesis market report:
Why are the keratoprosthesis market players targeting region for increased product sales?
What patented technologies are the players utilizing in the global keratoprosthesis market?
Which regions are displaying the fastest growth in the keratoprosthesis market?
What are the underlying micro- macroeconomic factors affecting the global keratoprosthesis market?
Request TOC of this Report - https://www.factmr.com/connectus/sample?flag=T&rep_id=859
Why choose Fact.MR?
Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.
Use of Diaton tonometer in Boston keratoprosthesis KPro Type 1 more at http://www.tonometerdiaton.com/index.php?do=home.viewNews&item=Transpalpebral_Transcleral_Tactile_Intraocular_Pressure_Measurements_in_Eyes_with_Type_1_Boston_Keratoprosthesis
Agreement among Transpalpebral,Transcleral and Tactile Intraocular Pressure Measurements in Eyes with Type 1 Boston Keratoprosthesis
Jessica L.Liu, Thasarat S.Vajaranant,Maria S.Cortina, Jacob T.Wilensky. Glaucoma, University of Illinois at Chicago, Chicago, IL
Purpose: The use of keratoprostheses (KPro) to restore vision in eyes with corneal opacities has become increasingly popular in the last five years. Intraocular pressure (IOP) is a cardinal measurement employed in glaucoma management. This presents a major problem since glaucoma remains a major visual limiting factor in eyes with KPro and most forms of tonometry require an intact cornea. The purpose of this study is to determine if transpalpebral IOP measurement can be an alternative method of measuring IOP and yield valuable data in eyes with KPro. Methods: We retrospectively reviewed IOP measurements in patients who had received Type 1 Boston KPro, and their IOP were estimated by three different methods during routine visits to their cornea! surgeon. The surgeon estimated the IOP range tactilely by palpation of the globe. A pneumatonometer(Model 30 Classic; Mentor, BioRad, Santa Ana, California, USA) was used to measure IOP by placing the tonometer tip on the sclera peripherally to the contact lens in the inferotemporal quadrant. The Diaton tonometer (BiCOM, Inc., Long Beach, NY, USA) was used to obtain values through the upper lid in accordance with the instructions by the manufacturer. An average of two Diaton IOP measurements was used in the analysis. Since the tactile IOP were recorded as a range rather than a definite number, we computed the percent agreement, the percentage of eyes in which pneumatometer or Diaton lOPs were within 2 mmHg of the tactile IOP range. Two-tailed t-test was used to compare the mean of pneumatonometer and Diaton IOP measurements. Results: The analysis included 23 eyes of 20 patients. The percentage agreement was 85% between tactile range and pnematonometer lOPs, and 95% between tactile range and Diaton lOPs. Pneumatonometer consistently yielded higher IOP values, compared to Diaton (p=0.04). The overall IOP mean ± SD was 17.2 ± 6 mmHg for pneumatonometer and 13.8± 5 mmHg for Diaton tonometer. Conclusions: The presence of KPro did not appear to interfere with IOP with Diaton tonometer, and Diaton tonometer yielded IOP readings that were similar to those obtained by palpation. Scleral pneumotonometry yielded values that were consistently higher than tactile estimates and Diaton IOP. In addition to routine IOP estimates by palpation, transcleral and transpalpebral IOP measurements can be considered to monitor patients with KPro.